India Gets Relief as US Waives 100% Tariff on Select Specialty Medicines
What Happened
The US has exempted certain specialty medicines and ingredients from its upcoming 100% tariff, giving relief to India and 19 other countries. The exemption covers drugs for rare diseases, infertility, cell and gene therapies, antibody-drug conjugates, and animal health products. Generic medicines are also not affected.
Key Takeaways
The move protects a high-value segment of India's pharmaceutical exports to the US even as Washington moves ahead with steep tariffs on some patented drug imports to encourage domestic manufacturing.